deals, IPOs, M&A

Year’s Best Exits—Top Massachusetts IPOs and M&As of 2007

Robert Buderi 1/9/08

(Page 2 of 2)

which include the firms’ names, their fields, who bought them in the case of M&As, and the deal value. Once again the data comes courtesy of Dow Jones VentureSource.

*****

Top 10 Massachusetts M&As of 2007 (by purchase price)

Health Dialog (Boston): Decision support services. Acquired by BUPA (United Kingdom) — $775 Million

Adnexus Therapeutics (Waltham): Biotechnology. Acquired by Bristol-Myers Squibb — $430 million

Domantis (Waltham): Biotechnology. Acquired by GlaxoSmithKline — $406 million

Hypnion (Lexington): Pharmaceuticals. Acquired by Eli Lilly — $315 million

Alantos Pharmaceuticals (Cambridge): Biotechnology. Acquired by Amgen — $300 million

VoiceSignal Technologies (Woburn): Connectivity and communications software. Acquired by Nuance Communications — $293 million

Acopia Networks (Lowell): Connectivity and communications software. Acquired by F5 Networks — $210 million

Spotfire (Somerville): Business applications software. Acquired by Tibco Software — $195 million

Interwise (Cambridge): Business applications software. Acquired by AT&T — $121 million

Archivas (Waltham): Database software. Acquired by Hitachi — $120 million

*****

Top 10 Massachusetts IPOs of 2007 (by dollars raised)

Starent Networks (Tewksbury) — Wireless communications equipment — $108 million

Netezza (Framingham) — Data storage — $108 million

Constant Contact (Waltham) — IT business services — $93.3 million

EnerNOC (Boston) — Energy conservation products — $91.7 million

Athenahealth (Watertown) — Decision support services for medical practices — $90 million

TechTarget (Needham) — Media, content & information — $83.6 million (Editor’s note: we applaud all media-content company IPOs, but feel they are all undervalued)

Molecular Insight Pharmaceuticals (Cambridge) — Biotechnology — $70 million

BladeLogic (Lexington) — Connectivity and communications software — $67 million

Virtusa (Westborough) — IT consulting — $61.6 million

Sirtris Pharmaceuticals (Cambridge) — Biotechnology — $60 million